Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlanbia Regulatory News (GLB)

Share Price Information for Glanbia (GLB)

Share Price is delayed by 15 minutes
Get Live Data
21.20    0.00 (0.00%)
Bid:
21.20
Ask:
22.00
Spread: 0.80 (3.774%)
Market Cap: €5.12b
GLB Live PriceLast checked at - London Stock Exchange

Intraday Glanbia Share Chart

Transaction in Own Shares

20 Jan 2022 12:11

RNS Number : 1288Z
Glanbia PLC
20 January 2022
 

Glanbia plc Transaction in Own Shares

 

20 January 2022, Glanbia plc ("Glanbia" or "the Company"), the global nutrition Company has been informed that Glanbia Co-operative Society ("the Co-op") has completed the sale of approximately 5.75 million ordinary shares in the Company (the "Shares"), representing around 2 percent of the Company's issued share capital, for a total consideration of approximately €70 million (the "Equity Placement"). Concurrently with the Equity Placement, the Co-op placed EUR 250 million senior secured bonds and certain subscribers to these bonds placed existing Shares (the "Delta Shares") together with the Equity Placement (the "Placement")

The price per Share in the Placement was €12.25 and was determined by a book-build offering to institutional investors with settlement expected to occur on or around 24 January 2022.

Pursuant to the Company's existing authority to repurchase shares, the Company has participated in the Placement via Glanbia's broker Davy and today purchased 2,527,152 Shares (representing around 0.9 percent of the Company's existing issued share capital), at a price of €12.25 per Share (the "Buyback"). The Shares purchased in the Buyback will be cancelled. Following settlement of the above transaction and subsequent share cancellation Glanbia will have 284,022,805 ordinary shares in issue.

The purchase of shares from the Co-op as part of the Buyback constitutes a related party transaction for the Company under the Euronext Listing Rules ("Euronext LR") and the FCA Listing Rules ("FCA LR"). Pursuant to paragraph 11.1.15 (2)(a) of the Euronext LR and paragraph 11.1.10 (2)(b) of the FCA LR, Davy Corporate Finance confirms that the terms of the Buyback with the related party, are fair and reasonable as far as the shareholders of the Company are concerned.

The Buyback completed today by the Company is incremental to the ongoing €50 million share repurchase programme announced on 8 December 2021.

ENDS

For further information please contact:

Glanbia plc +353 56 777 2200

Mark Garvey, Group Finance Director

Liam Hennigan, Group Director of Strategic Planning & Investor Relations: +353 86 046 8375

Martha Kavanagh, Head of Corporate Communications: +353 87 646 2006

 

Davy +353 1 679 7788

Ivan Murphy/Ronan Veale

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBDGDBIGDDGDG
Date   Source Headline
9th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20264:24 pmRNSTotal Voting Rights
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20266:28 pmRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20262:36 pmRNSDirector/PDMR Shareholding
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
1st May 20263:38 pmRNSResult of AGM
30th Apr 20264:27 pmRNSTotal Voting Rights
29th Apr 20267:00 amRNSFirst Quarter 2026 Interim Management Statement
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 202611:31 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20262:53 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.